Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4649825
Max Phase: Preclinical
Molecular Formula: C22H20F3N7S
Molecular Weight: 471.51
Molecule Type: Unknown
Associated Items:
ID: ALA4649825
Max Phase: Preclinical
Molecular Formula: C22H20F3N7S
Molecular Weight: 471.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nsc(N2CC3CCC(C2)C3Nc2nc3c(-c4ccc(F)c(F)c4F)cccn3n2)n1
Standard InChI: InChI=1S/C22H20F3N7S/c1-11-26-22(33-30-11)31-9-12-4-5-13(10-31)19(12)27-21-28-20-15(3-2-8-32(20)29-21)14-6-7-16(23)18(25)17(14)24/h2-3,6-8,12-13,19H,4-5,9-10H2,1H3,(H,27,29)
Standard InChI Key: IAINSZMFDDIZGX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 471.51 | Molecular Weight (Monoisotopic): 471.1453 | AlogP: 4.30 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.24 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.84 | CX Basic pKa: 2.68 | CX LogP: 5.45 | CX LogD: 5.45 |
Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.45 | Np Likeness Score: -1.42 |
1. Rodríguez Sarmiento RM, Bissantz C, Bylund J, Limberg A, Neidhart W, Jakob-Roetne R, Wang L, Baumann K.. (2020) Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere., 63 (15): [PMID:32706964] [10.1021/acs.jmedchem.0c00909] |
Source(1):